Registro:

Referencias:

• Freitag, J., Immunometabolism and autoimmunity (2016) Immunol. Cell Biol., 94, pp. 925-934
• Theofilopoulos, A.N., The multiple pathways to autoimmunity (2017) Nat. Immunol., 18, pp. 716-724
• Caspi, R.R., Immunotherapy of autoimmunity and cancer: the penalty for success (2008) Nat. Rev. Immunol., 8, pp. 970-976
• Cerliani, J.P., Translating the 'sugar code’ into immune and vascular signaling programs (2017) Trends Biochem. Sci., 42, pp. 255-273
• Li, Y.J., A possible suppressive role of galectin-3 in upregulated osteoclastogenesis accompanying adjuvant-induced arthritis in rats (2009) Lab. Invest., 89, pp. 26-37
• Stys, P.K., Will the real multiple sclerosis please stand up? (2012) Nat. Rev. Neurosci., 13, pp. 507-514
• Stancic, M., Increased expression of distinct galectins in multiple sclerosis lesions (2011) Neuropathol. Appl. Neurobiol., 37, pp. 654-671
• Toscano, M.A., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death (2007) Nat. Immunol., 8, pp. 825-834
• Ilarregui, J.M., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat. Immunol., 10, pp. 981-991
• Mari, E.R., Galectin-1 is essential for the induction of MOG35-55-based intravenous tolerance in experimental autoimmune encephalomyelitis (2016) Eur. J. Immunol., 46, pp. 1783-1796
• Starossom, S.C., Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration (2012) Immunity, 37, pp. 249-263
• Zhu, C., The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity (2005) Nat. Immunol., 6, pp. 1245-1252
• Oomizu, S., Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner (2012) Clin. Immunol., 143, pp. 51-58
• Madireddi, S., Regulatory T cell-mediated suppression of inflammation induced by DR3 signaling is dependent on galectin-9 (2017) J. Immunol., 199, pp. 2721-2728
• Steelman, A.J., Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis (2013) J. Biol. Chem., 288, pp. 23776-23787
• Saresella, M., A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis (2014) FASEB J., 28, pp. 5000-5009
• Burman, J., Svenningsson, A., Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis (2016) J. Neuroimmunol., 292, pp. 40-44
• Jiang, H.R., Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis (2009) J. Immunol., 182, pp. 1167-1173
• James, R.E., Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis (2016) Glia, 64, pp. 105-121
• Jeon, S.B., Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway (2010) J. Immunol., 185, pp. 7037-7046
• Franco, P.G., Paving the way for adequate myelination: the contribution of galectin-3, transferrin and iron (2015) FEBS Lett., 589, pp. 3388-3395
• Hoyos, H.C., Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination (2014) Neurobiol. Dis., 62, pp. 441-455
• Hoyos, H.C., The role of galectin-3: from oligodendroglial differentiation and myelination to demyelination and remyelination processes in a cuprizone-induced demyelination model (2016) Adv. Exp. Med. Biol., 949, pp. 311-332
• Semerano, L., Novel immunotherapeutic avenues for rheumatoid arthritis (2016) Trends Mol. Med., 22, pp. 214-229
• Rabinovich, G.A., Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis (1999) J. Exp. Med., 190, pp. 385-398
• Iqbal, A.J., Endogenous galectin-1 exerts tonic inhibition on experimental arthritis (2013) J. Immunol., 191, pp. 171-177
• Huang, Y.J., Multivalent structure of galectin-1–nanogold complex serves as potential therapeutics for rheumatoid arthritis by enhancing receptor clustering (2012) Eur. Cell Mater., 23, pp. 170-181
• Wang, C.R., Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced arthritis (2010) Gene Ther., 17, pp. 1225-1233
• Xibille-Friedmann, D., A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis (2013) Scand. J. Rheumatol., 42, pp. 102-107
• Forsman, H., Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis (2011) Arthritis Rheum., 63, pp. 445-454
• Filer, A., Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways (2009) Arthritis Rheum., 60, pp. 1604-1614
• Ezzat, M.H., Elevated production of galectin-3 is correlated with juvenile idiopathic arthritis disease activity, severity, and progression (2011) Int. J. Rheum. Dis., 14, pp. 345-352
• Issa, S.F., Galectin-3 is persistently increased in early rheumatoid arthritis (RA) and associates with anti-CCP seropositivity and MRI bone lesions, while early fibrosis markers correlate with disease activity (2017) Scand. J. Immunol., 86, pp. 471-478
• Issa, S.F., Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets (2017) Arthritis Res. Ther., 19, p. 80
• Eshkar Sebban, L., The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation (2007) J. Immunol., 179, pp. 1225-1235
• Pál, Z., Non-synonymous single nucleotide polymorphisms in genes for immunoregulatory galectins: association of galectin-8 (F19Y) occurrence with autoimmune diseases in a Caucasian population (2012) Biochim. Biophys. Acta, 1820, pp. 1512-1518
• Seki, M., Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts (2007) Arthritis Rheum., 56, pp. 3968-3976
• Lee, J., Underexpression of TIM-3 and blunted galectin-9-induced apoptosis of CD4+ T cells in rheumatoid arthritis (2012) Inflammation, 35, pp. 633-637
• Seki, M., Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis (2008) Clin. Immunol., 127, pp. 78-88
• Arikawa, T., Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages (2009) Clin. Immunol., 133, pp. 382-392
• Atkinson, M.A., Type 1 diabetes (2014) Lancet, 383, pp. 69-82
• Herold, K.C., Type 1 diabetes: translating mechanistic observations into effective clinical outcomes (2013) Nat. Rev. Immunol., 13, pp. 243-256
• Perone, M.J., Suppression of autoimmune diabetes by soluble galectin-1 (2009) J. Immunol., 182, pp. 2641-2653
• Wu, G., Ganglioside GM1 deficiency in effector T cells from NOD mice induces resistance to regulatory T-cell suppression (2011) Diabetes, 60, pp. 2341-2349
• Gomez-Tourino, I., Galectin-1 synthesis in type 1 diabetes by different immune cell types: reduced synthesis by monocytes and Th1 cells (2011) Cell. Immunol., 271, pp. 319-328
• Chou, F.C., Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice (2009) Eur. J. Immunol., 39, pp. 2403-2411
• Chou, F.C., Overexpression of galectin-9 in islets prolongs grafts survival via downregulation of Th1 responses (2013) Cell Transplant., 22, pp. 2135-2145
• Kanzaki, M., Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes (2012) Endocrinology, 153, pp. 612-620
• Karlsen, A.E., Immune-mediated beta-cell destruction in vitro and in vivo – a pivotal role for galectin-3 (2006) Biochem. Biophys. Res. Commun., 344, pp. 406-415
• Mensah-Brown, E.P., Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice (2009) Clin. Immunol., 130, pp. 83-88
• Saksida, T., Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro (2013) J. Cell. Physiol., 228, pp. 1568-1576
• Ordas, I., Ulcerative colitis (2012) Lancet, 380, pp. 1606-1619
• Baumgart, D.C., Sandborn, W.J., Crohn's disease (2012) Lancet, 380, pp. 1590-1605
• Block, M., Immunohistochemical studies on galectin expression in colectomised patients with ulcerative colitis (2016) BioMed Res. Int., 2016
• Demetter, P., The galectin family and digestive disease (2008) J. Pathol., 215, pp. 1-12
• Papa Gobbi, R., A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders (2016) Biofactors, 42, pp. 93-105
• Tsai, H.F., Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis (2016) J. Mol. Med., 94, pp. 545-556
• Lippert, E., Galectin-3 modulates experimental colitis (2015) Digestion, 92, pp. 45-53
• Simovic Markovic, B., Galectin-3 plays an important pro-inflammatory role in the induction phase of acute colitis by promoting activation of NLRP3 inflammasome and production of IL-1beta in macrophages (2016) J. Crohns Colitis, 10, pp. 593-606
• Müller, S., Galectin-3 modulates T cell activity and is reduced in the inflamed intestinal epithelium in IBD (2006) Inflamm. Bowel Dis., 12, pp. 588-597
• Lippert, E., Regulation of galectin-3 function in mucosal fibroblasts: potential role in mucosal inflammation (2008) Clin. Exp. Immunol., 152, pp. 285-297
• Jensen-Jarolim, E., The constitutive expression of galectin-3 is downregulated in the intestinal epithelia of Crohn's disease patients, and tumour necrosis factor alpha decreases the level of galectin-3-specific mRNA in HCT-8 cells (2002) Eur. J. Gastroenterol. Hepatol., 14, pp. 145-152
• Hokama, A., Induced reactivity of intestinal CD4+ T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation (2004) Immunity, 20, pp. 681-693
• Nishida, A., Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cells (2012) J. Exp. Med., 209, pp. 2383-2394
• Paclik, D., Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle (2008) PLoS One, 3
• Paclik, D., Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice (2008) J. Mol. Med., 86, pp. 1395-1406
• Santucci, L., Galectin-1 suppresses experimental colitis in mice (2003) Gastroenterology, 124, pp. 1381-1394
• Muglia, C.I., Inflammation controls sensitivity of human and mouse intestinal epithelial cells to galectin-1 (2016) J. Cell. Physiol., 231, pp. 1575-1585
• Moulton, V.R., Pathogenesis of human systemic lupus erythematosus: a cellular perspective (2017) Trends Mol. Med., 23, pp. 615-635
• Liu, S.D., Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB × NZW) F1 mice from lupus-like disease (2011) Lupus, 20, pp. 473-484
• Moritoki, M., Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3 (2013) PLoS One, 8
• Deak, M., Novel role for galectin-1 in T-cells under physiological and pathological conditions (2015) Immunobiology, 220, pp. 483-489
• Shi, Z., The involvement of galectin -3 in skin injury in systemic lupus erythematosus patients (2017) Lupus, , https://doi.org/961203317736144, Published online October 23, 2017
• Montiel, J.L., Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus (2010) Scand. J. Rheumatol., 39, pp. 50-57
• Shi, Z.R., Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus (2015) Arthritis Rheumatol., 67, pp. 193-203
• Massardo, L., Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation (2009) Lupus, 18, pp. 539-546
• Vicuna, L., Galectin-8 binds to LFA-1, blocks its interaction with ICAM-1 and is counteracted by anti-Gal-8 autoantibodies isolated from lupus patients (2013) Biol. Res., 46, pp. 275-280
• Nabi, I.R., The galectin lattice at a glance (2015) Cell Sci., 128, pp. 2213-2219
• Guardia, C.M., Structural basis of redox-dependent modulation of galectin-1 dynamics and function (2014) Glycobiology, 24, pp. 428-441
• Hiramatsu, H., Involvement of histidine residues in the pH-dependent β-galactoside binding activity of human galectin-1 (2013) Biochemistry, 52, pp. 2371-2380
• Rosenblum, M.D., Treating human autoimmunity: current practice and future prospects (2012) Sci. Transl. Med., 4
• Vasta, G.R., Galectins as pattern recognition receptors: structure, function, and evolution (2012) Adv. Exp. Med. Biol., 946, pp. 21-36
• Cagnoni, A.J., Turning-off signaling by siglecs, selectins, and galectins: chemical inhibition of glycan-dependent interactions in cancer (2016) Front. Oncol., 6, p. 109
• Thiemann, S., Baum, L.G., Galectins and immune responses – just how do they do those things they do? (2016) Annu. Rev. Immunol., 34, pp. 243-264
• Bonzi, J., Pre-B cell receptor binding to galectin-1 modifies galectin-1/carbohydrate affinity to modulate specific galectin-1/glycan lattice interactions (2015) Nat. Commun., 6
• Nio-Kobayashi, J., Tissue- and cell-specific localization of galectins, beta-galactose-binding animal lectins, and their potential functions in health and disease (2017) Anat. Sci. Int., 92, pp. 25-36
• Lee, S.U., N-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration (2007) J. Biol. Chem., 282, pp. 33725-33734
• Green, R.S., Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis (2007) Immunity, 27, pp. 308-320
• Togayachi, A., Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activation (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 15829-15834
• Kudelka, M.R., Cosmc is an X-linked inflammatory bowel disease risk gene that spatially regulates gut microbiota and contributes to sex-specific risk (2016) Proc. Natl. Acad. Sci. U. S. A., 113, pp. 14787-14792
• Commodaro, A.G., Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation (2011) Autoimmun. Rev., 10, pp. 205-209
• Toscano, M.A., Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses (2006) J. Immunol., 176, pp. 6323-6332
• Zanon Cde, F., Protective effects of the galectin-1 protein on in vivo and in vitro models of ocular inflammation (2015) Mol. Vis., 21, pp. 1036-1050
• Romero, M.D., Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis (2006) Invest. Ophthalmol. Vis. Sci., 47, pp. 1550-1556
• Sampson, J.F., Galectin-8 ameliorates murine autoimmune ocular pathology and promotes a regulatory T cell response (2015) PLoS One, 10
• Manns, M.P., Autoimmune hepatitis – update 2015 (2015) J. Hepatol., 62, pp. S100-S111
• Santucci, L., Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice (2000) Hepatology, 31, pp. 399-406
• Lv, K., Galectin-9 ameliorates Con A-induced hepatitis by inducing CD4+CD25low/int effector T-cell apoptosis and increasing regulatory T cell number (2012) PLoS One, 7
• Ju, Y., The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis (2014) Mol. Immunol., 58, pp. 85-91
• Liberal, R., The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway (2012) Hepatology, 56, pp. 677-686
• Volarevic, V., Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice (2012) Hepatology, 55, pp. 1954-1964
• Volarevic, V., Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury (2015) Eur. J. Immunol., 45, pp. 531-543
• Silva, C.A., Diagnosis and classification of autoimmune orchitis (2014) Autoimmun. Rev., 13, pp. 431-434
• Perez, C.V., Dual roles of endogenous and exogenous galectin-1 in the control of testicular immunopathology (2015) Sci. Rep., 5
• McLachlan, S.M., Rapoport, B., Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity (2014) Endocr. Rev., 35, pp. 59-105
• Leskela, S., Graves’ disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells (2015) PLoS One, 10
• Bellutti Enders, F., Correlation of CXCL10, tumor necrosis factor receptor type II, and galectin 9 with disease activity in juvenile dermatomyositis (2014) Arthritis Rheumatol., 66, pp. 2281-2289
• Zhang, R., Increased levels of serum galectin-3 in patients with primary Sjögren's syndrome: associated with interstitial lung disease (2014) Cytokine, 69, pp. 289-293

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------